Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers. (17th September 2017)

• Record Type: Journal Article
• Authors: Cobianchi, Stefano; Jaramillo, Jessica; Luvisetto, Siro; Pavone, Flaminia; Navarro, Xavier
• Is Part Of: Neuroscience. Volume 359(2017)
• Page Start: 82
• Page End: 91
• Publication Date: 2017-09-17
• Subjects: ANOVA analysis of variance -- BoNT/A Botulinum neurotoxin type A -- CCI chronic constriction injury -- CMAP compound muscle action potential -- CNAP compound nerve action potential -- dpi days post-injury -- GN gastrocnemius medialis -- i.n. intranerve -- i.p. intraperitoneal -- i.p.l. intraplantar -- PL plantar interossei -- SCs Schwann cells -- SNAP-25 synaptosomal-associated protein of 25 kDa -- SNC sciatic nerve crush; botulinum toxin -- axonal regeneration -- hyperalgesia -- functional recovery; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2017.07.011
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: An intranerve injection of botulinum toxin A (BoNT/A) was able to stimulate the regeneration of injured peripheral nerve. The dose used was very low and ineffective to negatively affect motor and sensory function as usually described. BoNT/A particularly stimulated the regeneration of regrowing myelinated axons. Muscular reinnervation was enhanced by BoNT/A injection. Normal skin innervation was not affected by BoNT/A injection. Abstract: The injection of safe doses of botulinum neurotoxin A (BoNT/A) have been reported to be useful for the treatment of neuropathic pain, but it is still unknown how functional recovery is induced after peripheral nerve injury. We evaluated the effects of intranerve application of BoNT/A, on regeneration and sensorimotor functional recovery in partial and complete peripheral nerve injuries in the mouse. After sciatic nerve crush (SNC) and intranerve delivery of BoNT/A (15 pg), axonal regeneration was measured by nerve pinch test at different days. Regeneration of myelinated and unmyelinated fibers was assessed by immunohistochemical double labeling for NF200/GAP43 and CGRP/GAP43. S100 was used as Schwann cells marker. Medial footpad skin reinnervation was assessed by PGP staining. Motor functions were assessed by means of nerve conduction tests. In other mice groups, nerve conduction tests were performed also after chronic constriction injury (CCI) of the sciatic nerve and intraplantar injection of BoNT/A (15 pg). In SNC mice, BoNT/A increased the rate of axonal regeneration. The advantage of regrowing myelinated axons after BoNT/A injection was evidenced by longer NF200+ nerve profiles and confirmed by nerve histology. We observed also a higher expression of S100 in the distal portion of BoNT/A-injected regenerated nerves. In CCI mice, BoNT/A induced an increase in reinnervation of gastrocnemius and plantar muscles. These results show that a low dose of BoNT/A, insufficient to produce muscular dysfunction, conversely speeds up sensorimotor recovery by stimulating myelinated axonal regeneration, and points out its application as a multipotent treatment for peripheral neuropathies.